[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340876-105":59,"doc-detail-340876-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-analysis-identifies-gabrb3-asa-biomarker-in-prostate-cancer-research-open-access","Integrated analysis identifies GABRB3 asa biomarker in prostate cancer - Research Open Access","","Advanced prostate cancer frequently shows treatment failure after androgen deprivation therapy (ADT), creating an urgent need to clarify genetic drivers that shape patient outcomes. The study focuses on the PI3K/AKT signaling pathway and tests whether pathway-related genetic variants influence clinical results under ADT. In a cohort of 630 ADT-treated patients, integrated statistical and functional analyses identify GABRB3 as a prognostic biomarker.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-analysis-identifies-gabrb3-asa-biomarker-in-prostate-cancer-research-open-access/340876/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-analysis-identifies-gabrb3-asa-biomarker-in-prostate-cancer-research-open-access/340876.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is genetic analysis important in androgen deprivation therapy for prostate cancer?","Question",{"text":112,"@type":113},"Treatment failure after ADT remains a major management challenge. Identifying genetic factors may enable more personalized treatments and improved therapeutic strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was GABRB3 linked to clinical outcomes in the study?",{"text":117,"@type":113},"The study genotyped 399 SNPs across 28 PI3K/AKT pathway genes and used survival analyses with multivariate Cox regression and correction for multiple testing. GABRB3 rs12591845 showed the strongest association with overall and cancer-specific survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports GABRB3 as a role in prostate tumor biology?",{"text":121,"@type":113},"A pooled analysis across 16 independent gene expression datasets showed higher GABRB3 expression in prostate cancer tissues than in normal tissues. Gene set enrichment analysis further indicated altered pathways, suggesting involvement in tumor-related processes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340876,1790519317,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Chen et al. BMC Medical Genomics (2024) 17:41 BMC Medical Genomics  \n[https://doi.org/10.1186/s12920-024-01816-8](https://doi.org/10.1186/s12920-024-01816-8)  \nRESEARCH Open Access  \nIntegrated analysis identifies GABRB3 asa biomarker in prostate cancer  \nJun-Yan Chen 1†, Chi-Fen Chang2†, Shu-Pin Huang3,4,5†, Chao-Yuan Huang6, Chia-Cheng Yu7,8,9, Victor C. Lin 10,11, Jiun-Hung Geng3,4,12, Chia-Yang Li 13,14, Te-Ling Lu 1 and Bo-Ying Bao 1*  \nAbstract  \nBackground Treatment failure following androgen deprivation therapy (ADT) presents a significant challenge in the management of advanced prostate cancer. Thus, understanding the genetic factors influencing this process could facilitate the development of personalized treatments and innovative therapeutic strategies. The phosphoinositide 3-kinase (PI3K)/AKT signaling pathway plays a pivotal role in controlling cell growth and tumorigenesis. We hypothesized that genetic variants within this pathway may affect the clinical outcomes of patients undergoing ADT for prostate cancer.  \nMethods We genotyped 399 single-nucleotide polymorphisms (SNPs) across 28 core PI3K/AKT pathway genes in a cohort of 630 patients with prostate cancer undergoing ADT. We assessed the potential association of the SNPs with patient survival. Functional analyses of the implicated genes were also performed to evaluate their effects on prostate cancer.  \nResults After multivariate Cox regression analysis and multiple testing correction, GABRB3 rs12591845 exhibited the most significant association with both overall and cancer-specific survivals (P \u003C 0. 003) . A comprehensive pooled analysis of 16 independent gene expression datasets revealed elevated expression of GABRB3 in prostate cancer tissues compared to that in normal tissues (P \u003C 0. 001) . Furthermore, gene set enrichment analysis unveiled differential enrichment of pathways such as myogenesis, interferon γ and α responses, and the MYC proto-oncogene pathway in tumors with elevated GABRB3 expression, implying a role for GABRB3 in prostate cancer.  \nConclusion Our results suggest that rs12591845 could potentially serve as a valuable prognostic indicator for patients undergoing ADT. The potential role of GABRB3 in promoting prostate tumorigenesis is also highlighted. Keywords PI3K/AKT pathway, GABRB3, Prostate cancer, Survival, Gene set enrichment analysis  \n†Jun-Yan Chen, Chi-Fen Chang and Shu-Pin Huang contributed equally to this work.  \n*Correspondence:  \nBo-Ying Bao [bao@mail.cmu.edu.tw](bao@mail.cmu.edu.tw)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nChen et al. BMC Medical Genomics (2024) 17:41  \nIntroduction  \nProstate cancer is a significant health concern and the leading cause of cancer-related fatalities in men, accounting for over 1.4 million new diagnoses and approx","cbCaieLlaVx5Jcpa","https://ap.wps.com/l/cbCaieLlaVx5Jcpa","pdf",2560601,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why is genetic analysis important in androgen deprivation therapy for prostate cancer?\",\"answer\":\"Treatment failure after ADT remains a major management challenge. Identifying genetic factors may enable more personalized treatments and improved therapeutic strategies.\"},{\"question\":\"How was GABRB3 linked to clinical outcomes in the study?\",\"answer\":\"The study genotyped 399 SNPs across 28 PI3K/AKT pathway genes and used survival analyses with multivariate Cox regression and correction for multiple testing. GABRB3 rs12591845 showed the strongest association with overall and cancer-specific survival.\"},{\"question\":\"What evidence supports GABRB3 as a role in prostate tumor biology?\",\"answer\":\"A pooled analysis across 16 independent gene expression datasets showed higher GABRB3 expression in prostate cancer tissues than in normal tissues. Gene set enrichment analysis further indicated altered pathways, suggesting involvement in tumor-related processes.\"}]","Integrated analysis identifies GABRB3 asa biomarker in prostate cancer - Research Open Access | PDF",1790039284,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6ae6482cdac70795ea781bb400427e1.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81c2492028d79a5f5659b94be8f8094d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8ce23eef85ac5dc7f993f333951e2c0.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91a173e6e6e3bb4e165e9dc9495d3a45.webp",980,1306]